TMC-95A, a reversible proteasome inhibitor, induces neurite outgrowth in PC12 cells

Bioorg Med Chem Lett. 2004 Feb 9;14(3):663-5. doi: 10.1016/j.bmcl.2003.11.043.

Abstract

TMC-95A has been characterized as a potent proteasome inhibitor that binds to enzymes non-covalently at low nanomolar concentrations. Herein, the neuritogenic activity of TMC-95A in PC12 rat pheochromocytoma cells is reported for the first time. TMC-95A induced a positive neurite initiation of PC12 cells at concentration ranging from 1 to 20 microM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ascomycota / chemistry*
  • Cysteine Endopeptidases / drug effects*
  • Molecular Structure
  • Multienzyme Complexes / drug effects*
  • Neurites / drug effects*
  • Neurites / physiology
  • PC12 Cells
  • Peptides, Cyclic / isolation & purification
  • Peptides, Cyclic / pharmacology*
  • Protease Inhibitors / isolation & purification
  • Protease Inhibitors / pharmacology*
  • Proteasome Endopeptidase Complex
  • Rats

Substances

  • Multienzyme Complexes
  • Peptides, Cyclic
  • Protease Inhibitors
  • TMC-95A
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex